Dr. Van Den Anker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave Nw
Washington, DC 20010Phone+1 202-884-5448- Is this information wrong?
Education & Training
- Erasmus University Rotterdam Faculty of MedicineClass of 1983
Certifications & Licensure
- DC State Medical License 2002 - 2024
- OH State Medical License 2002 - 2005
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 12 citationsCorrection to: Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.Victoria C. Ziesenitz, Janelle D. Vaughns, Gilbert Koch, Gerd Mikus, Johannes N. van den Anker
Clinical Pharmacokinetics. 2018-03-01 - 80 citationsLong-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia.Dirk Bassler, Eric S. Shinwell, Mikko Hallman, Pierre-Henri Jarreau, Richard Plavka
The New England Journal of Medicine. 2018-01-10 - 25 citationsFirst-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm NeonatesJanneke M. Brussee, Huixin Yu, Elke H. J. Krekels, Berend de Roos, Margreke J. E. Brill
CPT. 2018-06-01
Grant Support
- Optimizing The Use Of Methadone In Newborn InfantsNational Institute On Drug Abuse2010–2012
- Pediatric Toxicity And Efficacy In Long-Term Systemic Treatment With Anti-SenseEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- Metabolism And Toxicity Of Acetaminophen In Preterm InfantsEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
- Multiple Dose Pharmacokinetic Study Of Meropenem In Young Infants (91 Days)National Center For Research Resources2010
- Antimicrobial Pharmacokinetics In High Risk InfantsNational Center For Research Resources2010
- Clinical Trial: Optimizing Pain Treatment In Pre-Term NeonatesNational Center For Research Resources2009–2010
- Optimizing The Use Of Morphine In Preterm InfantsEunice Kennedy Shriver National Institute Of Child Health &Human Development2005–2009
- Washington D.C. Collaborative PpruEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2009
- Prevalence Of Proteinuria In Overweight AdolescentsNational Center For Research Resources2007–2008
- Optimizing Pain Treatment In Pre-Term NeonatesNational Center For Research Resources2005–2008
- Optimizing Pain Treatment In The Preterm InfantNational Center For Research Resources2004–2008
- Non-Invasive Assessment Of Opiate Analgesia In Children With Sickle Cell DiseaseEunice Kennedy Shriver National Institute Of Child Health &Human Development2006
- Network Of Pediatric Pharmacology Research UnitsEunice Kennedy Shriver National Institute Of Child Health &Human Development2002
- Pediatric Pharmacology Research UnitEunice Kennedy Shriver National Institute Of Child Health &Human Development2000–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: